Injectors and drive systems for injectors with non-stationary gas cylinders
The compact injector design addresses length and comfort issues by integrating a gas canister within the plunger, using an opener mechanism and actuator to deliver agents efficiently and comfortably.
Patent Information
- Application Number
- PCT/US2025/020136
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-03-16
- Filing Date
- 2025-03-16
- Publication Date
- 2025-09-25
AI Technical Summary
Conventional injectors, both spring-powered and gas-powered, face challenges in compactness and user comfort due to high forces, noise, and discomfort during administration, particularly for viscous fluids, with gas canisters occupying significant space and limiting device length.
A compact injector design incorporating a nested gas canister within a plunger or an elongated gas canister in place of a conventional plunger, utilizing an opener mechanism and actuator to release pressurized gas for delivering agents, with actuators like a screw or lever for manual activation.
The design achieves a more compact injector device that minimizes noise and discomfort, providing a consistent delivery rate for viscous fluids while maintaining device length and user comfort.
Smart Images

Figure US2025020136_25092025_PF_FP_ABST
Abstract
Description
INJECTORS AND DRIVE SYSTEMS FOR INJECTORS WITH NON-STATIONARY GAS CYLINDERS RELATED APPLICATION DATA
[0001] The present application claims benefit of co-pending U.S. provisional application Serial No. 63 / 566,233, filed March 16, 2024, the entire disclosure of which is expressly incorporated by reference herein. TECHNICAL FIELD
[0002] The present application relates generally to devices and methods for delivering agents into a subject’s body and, more particularly, to auto-injectors and / or gas- powered drive systems for injection devices, and to methods for making and using such devices. BACKGROUND
[0003] There are many applications involving delivery of a medicament or other agent subcutaneously, intramuscularly, or otherwise into a patient’s body. For example, auto-injectors are available that include a predetermined dose of the agent that may be delivered automatically into the patient’s body, e.g., after placement against the patient’s skin and activation. Manual injectors are also available that allow a user to manually deliver a desired dose of the agent.
[0004] Generally, auto-injectors are spring-loaded syringes that are activated to release the spring, which generates sufficient force to penetrate the skin with a needle and deliver the dose within the syringe. For viscous fluids, the forces required to develop fluid flow can be higher than spring-powered systems can provide. When springs can be used, they must generate a relatively high force that requires springs of high mass. Consequently, such auto-injectors may make substantial noise, create pressure spikes in the syringe leading to glass breakage, vibrate, and / or may drive the needle forcefully into the patient’s skin, which may cause pain and / or may startle the user, particularly when the patient is administering the injection themselves.
[0005] Gas-powered auto-injectors have also been developed, such as those disclosed in U.S. Patent Nos. 10,716,892, 10,912,883, and 11,071,824, the entire disclosures of which are expressly incorporated by reference herein. Gas-powered injectorsinclude a gas canister or container therein filled with pressurized gas that is used to power a plunger or other force-providing component to deliver one or more agents from the injector. The gas canister may take up a lot of space, particularly when positioned coaxially with the direction of injection while staying stationary and in series with another force providing component, e.g., a plunger. The length of the plunger and its displacement distance, as well as the length of the gas canister proximal to the plunger, may set a minimum length for the injector, making reducing the length of the injector device challenging if not impossible.
[0006] Therefore, improved devices and methods for delivering agents into a patient’s body, e.g., that are more compact than conventional injectors, would be useful. SUMMARY
[0007] The present application relates generally to devices and methods for delivering agents into a subject’s body and, more particularly, to injectors and / or gas- powered drive systems for injection devices, e.g., that may be more compact than conventional injector devices. For example, a plunger or other force providing component of an injector is generally the lengthiest component in the drive module, and nesting a gas canister and / or its opener mechanism within the plunger, or providing an elongated gas canister in place of a conventional plunger may reduce the length of the drive module, and provide a more compact injector device.
[0008] In accordance with one example, a drive module is provided for delivering one or more agents into a patient’s body from an injector module comprising an agent chamber containing one or more agents, an outlet, and a piston, the drive module including a drive housing including a first end and a second end and a first chamber therein; a plunger comprising a proximal end disposed within the first chamber and slidable from an initial position to an extended position wherein a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger configured to be coupled to the piston of the injector module; a canister at least partially received in the plunger such that canister follows movement of the plunger, the canister containing pressurized gas including an outlet; an opener mechanism within the drive housing adjacent the first end including an actuator pin disposed adjacent the outlet; and an actuator configured to move one of the opener mechanism and the canister to cause the actuator pin to open the outlet and cause the gas within the canister to flow into the first chamber to advance the plunger and canister, theplunger configured to advance the piston of the injector module to deliver the one or more agents from the agent chamber through the outlet.
[0009] In accordance with another example, a device is provided for delivering one or more agents into a patient’s body that includes an injector module comprising an injector housing carrying an agent chamber containing one or more agents, and a piston slidably disposed within the agent chamber. The device also includes a drive module including a drive housing including a first end and a second end and a first chamber therein; a plunger comprising a proximal end disposed within the first chamber and slidable from an initial position to an extended position wherein a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger coupled to the piston of the injector module; a canister at least partially received in the plunger such that canister follows movement of the plunger, the canister containing pressurized gas including an outlet; an opener mechanism within the drive housing adjacent the first end including an actuator pin disposed adjacent the outlet; and an actuator configured to move one of the opener mechanism and the canister to cause the actuator pin to open the outlet and cause the gas within the canister to flow into the first chamber to advance the plunger and canister, wherein the plunger advances the piston of the injector module to deliver the one or more agents from the agent chamber through the outlet.
[0010] In accordance with yet another example, a drive module is provided for delivering one or more agents into a patient’s body from an injector module comprising an agent chamber containing one or more agents, an outlet, and a piston, the drive module including a drive housing including a first end and a second end and a first chamber therein; a plunger comprising a proximal end disposed within the first chamber and slidable from an initial position to an extended position wherein a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger configured to be coupled to the piston of the injector module; a plunger chamber within the plunger containing pressurized gas and including an outlet adjacent the proximal end; an opener mechanism within the drive housing including an actuator pin disposed adjacent the outlet; and an actuator configured to move one of the opener mechanism and the canister to cause the actuator pin to open the outlet and cause the gas within the canister to flow into the first chamber to advance the plunger, the plunger configured to advance the piston of the injector module to deliver the one or more agents from the agent chamber.
[0011] In accordance with still another example, a device is provided for delivering one or more agents into a patient’s body that includes an injector module comprising an injector housing carrying an agent chamber containing one or more agents, and a piston slidably disposed within the agent chamber; and a drive module. The drive module includes a drive housing including a first end and a second end and a first chamber therein; a plunger comprising a proximal end disposed within the first chamber and slidable from an initial position to an extended position wherein a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger coupled to the piston of the injector module; a plunger chamber within the plunger containing pressurized gas and including an outlet adjacent the proximal end; an opener mechanism within the drive housing including an actuator pin disposed adjacent the outlet; and an actuator configured to move one of the opener mechanism and the canister to cause the actuator pin to open the outlet and cause the gas within the canister to flow into the first chamber to advance the plunger, the plunger configured to advance the piston of the injector module to deliver the one or more agents from the agent chamber.
[0012] Any of the injector devices described herein may include any of the actuators disclosed in the patents incorporated by reference herein. For example, an actuation sleeve may be provided that is retracted when the needle is inserted into a patient’s skin, thereby activating the opener mechanism to release the gas. Alternatively, a screw, lever, button, or other actuator may be provided on the drive module that may be manually activated by a user to actuate the opener mechanism to release the gas.
[0013] Other aspects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] It is believed the present invention will be better understood from the following description of certain examples taken in conjunction with the accompanying drawings, in which like reference numerals identify the same elements and in which:
[0015] FIG. 1 is a perspective view of an exemplary auto-injector device including a front and rear housing, and a safety cap.
[0016] FIGS. 2A and 2B are longitudinal cross-sections of an exemplary auto- injector device showing internal components of the device including a syringe carrying one or more agents.
[0017] FIGS. 3A and 3B are details of the distal end of the device of FIGS. 2A and 2B before use, showing a safety cap covering an activation cap and needle of the device.
[0018] FIGS. 4A-4C are cross-sections of the device of FIGS. 2A and 2B, showing activation of the device when the activation cap is displaced proximally when the device is pressed against a subject’s skin to puncture the skin with the needle, the activation cap causing a spacer and release cap to also displace proximally to release a carriage carrying an opener pin, causing the opener pin to advance distally to open a gas canister to release pressurized gas into a flow path within the device.
[0019] FIGS. 5A-5C are details of the proximal end of the device as shown in FIGS. 4A-4C, respectively.
[0020] FIGS. 6A and 6B are cross-sections of the device of FIGS. 2A and 2B after the pressurized gas is released, showing the pressurized gas advancing a plunger within the device to deliver one or more agents within the syringe through the needle, and advancing the activation cap when the needle is withdrawn from the subject’s skin.
[0021] FIG. 6C is a detail of the device as shown in FIG. 6B, showing a tab locking the activation cap after being advanced.
[0022] FIG. 7A is a cross-sectional schematic of an injector device, such as that shown in FIGS. 1-6, including a stationary gas canister and opener mechanism adjacent a plunger that is displaced by pressurized gas from the gas canister to advance a syringe piston to deliver an agent from a syringe.
[0023] FIG. 7B is a cross-sectional schematic of another injector device including a gas canister adjacent a plunger that is displaced by pressurized gas to advance a syringe piston to deliver an agent from a syringe.
[0024] FIGS. 8A and 8B are cross-sectional schematics of an injector device including a nested gas canister and opener mechanism within a plunger, showing the plunger in its initial position (FIG. 8A) and its extended position (FIG. 8B).
[0025] FIGS. 9A and 9B are cross-sectional schematics of another injector device including a gas canister integral with a plunger, showing the plunger in its initial position (FIG. 9A) and its extended position (FIG. 9B).
[0026] The drawings are not intended to be limiting in any way, and it is contemplated that various examples of the invention may be carried out in a variety of other ways, including those not necessarily depicted in the drawings. The accompanying drawings incorporated in and forming a part of the specification illustrate several aspects of the present invention, and together with the description serve to explain the principles of the invention; it being understood, however, that this invention is not limited to the precise arrangements shown. DETAILED DESCRIPTION
[0027] Before the examples are described, it is to be understood that the invention is not limited to particular examples described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular examples only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
[0028] Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
[0029] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, some potential and exemplary methods and materials are now described.
[0030] It must be noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a compound” includes a plurality of suchcompounds and reference to “the polymer” includes reference to one or more polymers and equivalents thereof known to those skilled in the art, and so forth.
[0031] Certain ranges are presented herein with numerical values being preceded by the term “about.” The term “about” is used herein to provide literal support for the exact number that it precedes, as well as a number that is near to or approximately the number that the term precedes. In determining whether a number is near to or approximately a specifically recited number, the near or approximating unrecited number may be a number which, in the context in which it is presented, provides the substantial equivalent of the specifically recited number.
[0032] Turning to the drawings, FIG. 1 shows an example of an auto-injector device 6 that includes an outer housing 8 including a front housing 10 carrying a syringe 70 containing one or more agents within an agent chamber, and a rear housing 12 including a drive assembly for automatically delivering the agent(s) from the syringe 70 when the device 6 is activated. As shown, a safety cap 86 is provided on the front housing 10 to prevent premature activation of the device 6, which may be removed immediately before an injection, as described further elsewhere herein. One or more internal components of the device 6 may move axially, i.e., proximally and / or distally relative to the longitudinal axis 18 when the device 6 is activated, as described further elsewhere herein.
[0033] In one example, the syringe 70 may be a pre-filled syringe, e.g., formed from glass, plastic, and the like, filled with a predetermined volume of agent, e.g., corresponding to a single dose for a patient. Alternatively, the agent chamber and needle may be integrated into the forward housing 10 if desired (not shown). In a further alternative, the syringe 70 (or integral agent chamber) may include a distal port (not shown) without a needle, such that a separate needle (also not shown) may be coupled to the port, e.g., using a Luer fitting, mating threads, and / or other cooperating connectors, immediately before an injection or otherwise as desired. As used herein, “agent” may include one or more flowable therapeutic and / or diagnostic compounds, medicaments, or materials, e.g., in liquid or gaseous form, in solution or suspension, and the like, such as viscous fluids.
[0034] Turning to FIGS 2A and 2B, an exemplary auto-injector device 6 is shown that includes an outer housing 8 including a front housing 10 carrying a syringe 70 containing one or more agents within an agent chamber 73, and a rear housing 12 including a drive assembly for automatically delivering the agent(s) from the syringe 70 when the device 6 is activated. As shown, a safety cap 86 is provided on the front housing 10 toprevent premature activation of the device 6, which may be removed immediately before an injection, as described further elsewhere herein. One or more internal components of the device 6 may move axially, i.e., proximally and / or distally relative to the longitudinal axis 18 when the device 6 is activated, as described further elsewhere herein.
[0035] In one example, the syringe 70 may be a pre-filled syringe, e.g., formed from glass, plastic, and the like, filled with a predetermined volume of agent, e.g., corresponding to a single dose for a patient. Alternatively, the agent chamber and needle may be integrated into the forward housing 10 if desired (not shown). In a further alternative, the syringe 70 (or integral agent chamber) may include a distal port (not shown) without a needle, such that a separate needle (also not shown) may be coupled to the port, e.g., using a Luer fitting, mating threads, and / or other cooperating connectors, immediately before an injection or otherwise as desired. As used herein, “agent” may include one or more flowable therapeutic and / or diagnostic compounds, medicaments, or materials, e.g., in liquid or gaseous form, in solution or suspension, and the like, such as viscous fluids.
[0036] With continued reference to FIGS. 2A and 2B, the syringe 70 includes a barrel 72 containing the agent(s) within agent chamber 73, a needle 78 extending from a distal end 72a of the barrel 72, and a piston or stopper 74 slidable within a proximal end 72b of the barrel 72 for directing the agent(s) through the needle 78 into the subject’s body (not shown). The device 6 also includes a gas canister or other source of pressurized gas 40 to power the device 6, e.g., to advance a plunger 50 coupled to the piston 74 to deliver the agent(s). The device 6 also includes an activation cap 80 and an opener mechanism 60 for opening the canister 40 to release pressurized gas within the canister 40 into a set of chambers of the device 6. For example, an inner housing 20 may be mounted within the outer housing 8 that includes a first or proximal chamber 22, e.g., within which the gas canister 40 is mounted, and a second or distal chamber 24, e.g., in which the plunger 50 is slidably received.
[0037] Generally, the device 6 is configured such that, when a contact surface 84 of the activation cap 80 is pressed against a subject’s skin to insert the needle 78, the activation cap 80 retracts proximally into the outer housing 8 and automatically activates the opener mechanism 60 to release the pressurized gas from the canister 40 into the first and second chambers 22, 24, which generates a distal force to advance the plunger 50 to deliver the agent(s) from the syringe 70 into the subject. After the injection is completed and thedevice 6 is withdrawn away from the skin, the activation cap 80 may automatically advance to cover the needle 78.
[0038] For example, a spacer 30 may be provided that extends between the activation cap 80 and a release cap 34 of the opener mechanism 60, e.g., such that proximal movement of the activation cap 80 is translated by the spacer 30 to the direct the release cap 34 proximally within the rear housing 12, which releases a spring perch assembly or carriage 64 of the opener mechanism 60, as described further elsewhere herein. The spacer 30 may be biased distally, e.g., by spring 32, which may, in turn, bias the activation cap 80 distally after completing the injection, also as described further elsewhere herein.
[0039] Generally, the outer housing 8 includes a proximal end 8a, e.g., provided on the rear housing 12, an open distal end 8b, e.g., provided on the forward housing 10, and an inner wall extending therebetween to enclose the interior of the device 6. The outer surface between the proximal and distal ends 8a, 8b may be sized and / or shaped to facilitate manipulation of the device 6, e.g., to facilitate placing and pressing the activation cap 80 against a subject’s skin to activate the device 6 and inject the agent(s). For example, the outer surface may have a generally cylindrical shape optionally including one or more textures or grip features to facilitate an operator (the subject themselves or a third party) holding the device 6 in one hand and pressing the activation cap 80 against the subject’s skin, as described further elsewhere herein. As shown, the proximal end 8a of the housing 8 may include a wall 8c enclosing the proximal end 8a and, optionally, one or more pockets or other features 8d for locking the release cap 34, as described further elsewhere herein.
[0040] The outer housing 8 may be formed from multiple, separate components, e.g., clamshell halves, e.g., formed from metal, such as stainless steel, aluminum, and the like, plastic, and / or composite material, by one or more of cold drawing, molding, casting, machining, and the like, that are substantially permanently attached together, e.g., by one or more of welding, soldering, fusing, bonding with adhesive, interference fit, and the like. As shown, the outer housing 8 is formed as separate forward and rear housings 10, 12, which may be assembled separately with respective internal components, and then coupled together, e.g., after loading a syringe 70 into the forward housing 10.
[0041] For example, during manufacturing, the forward housing 10 may be assembled with the activation cap 80 and safety cap 86, and a syringe 70 may be loaded into an interior of the forward housing 10, e.g., during manufacturing or during assembly of the device 6 any time before performing an injection. Optionally, as shown in FIGS. 3A and3B, the syringe 70 may include a rigid needle shield 79, e.g. formed from conventional materials, that may be removably secured to the distal end 72a of the barrel 72 to protect the needle and prevent accidental sticks. The safety cap 86 may include features 86a that engage the needle shield 79 such that, when the safety cap 86 is removed, the needle shield 79 is also removed. For example, as shown, the proximal end of the safety cap 86 may include one or more fingers 86a that fall into one or more corresponding cutouts, recesses, or other features on the needle shield 79 when the syringe 70 is inserted into the forward housing 10, thereby coupling the needle shield 79 to the safety cap 86, as described elsewhere herein.
[0042] The rear housing 12 may be assembled with the inner housing 20, the spacer 30, the release cap 34, the gas canister 40, the plunger 50, and the opener mechanism 60 (and any other incidental components), and the rear housing 12 may be coupled to the forward housing 10 at any time. For example, during manufacturing, a syringe 70 may be loaded into the interior of the forward housing 10, and the assembled rear housing 12 may be immediately coupled to the forward housing 10. When the rear housing 12 is attached to the forward housing 10, a distal end 54 of the plunger 50 may be coupled to the piston 74 within the syringe 70, e.g., such that distal movement of the plunger 50 is translated to the piston 74, as described further elsewhere herein.
[0043] As shown in FIGS. 2A and 2B, the outer housing 8 may include a mount 11, e.g., on one of the forward and rear housings 10, 12, for guiding and / or securing the syringe 70 during loading. Optionally, the proximal end 72b of the barrel 72 may include one or more flanges, e.g., a radial flange or a pair of opposing flanges, that may abut and / or be received within the mount 11 to secure the syringe 70 relative to the forward housing 10. In addition or alternatively, one or more detents, ridges, or other features (not shown) may be provided on the forward housing 10 for securing the syringe 70. Optionally, the forward housing 10 may include one or more windows 10c in the sidewall, which may facilitate observing the syringe 70 during an injection, e.g., to allow visual confirmation when the piston 74 is fully advanced.
[0044] Optionally, the device 6 may include a syringe spacer or adapter 75 that may provide an interface between a distal end 54 of the plunger 50 and the piston 74, e.g., to provide connectors therebetween and / or ensure proper spacing such that the piston 74 is advanced in conjunction with the plunger 50. For example, different length spacers 75 may be provided to allow different length syringes to be loaded into the forward housing 10while properly positioning the needle 78 adjacent the distal end 8b of the outer housing 8 and allowing the plunger 50 to be properly coupled to the piston 74.
[0045] During manufacturing or assembly, a syringe 70 may be selected that may be inserted into the housing 8, e.g., through the opening in the distal end 8b and coupled to the distal end 16 of the drive assembly 12. A syringe spacer 75 may be selected and its distal end 75a may be coupled to the piston 74, e.g., by one or more cooperating threads, as shown, one or more detents or other connectors, and the like. The distal end 54 of the plunger 50 may be inserted into a recess 75b in the syringe spacer 75 when the rear housing 12 is coupled to the forward housing 10. Optionally, the distal end 54 of the plunger 50 and the recess 75b may include cooperating locking features, e.g., one or more threads, detents, and the like (not shown) or the distal end 54 may simply be inserted into the recess 75b to coupled subsequent distal movement of the piston 74 to the plunger 50, as described further elsewhere herein.
[0046] Alternatively, the assembled housings 10, 12 may be packaged, stored, and / or otherwise prepared for subsequent assembly. For example, the housing 10, 12 may be shipped or otherwise provided to a manufacturer of the syringe 70, who may load the syringe 70 and couple the housings 10, 12 together to provide the finished device 6. In a further alternative, the assembled housings 10, 12 may be provided to a hospital, physician, or other medical professional, and final assembly may be completed immediately before performing an injection, which may allow a syringe including a specific agent to be loaded before an injection.
[0047] The proximal end 10a of the forward housing 10 and the distal end 12b of the rear housing 12 may include one or more cooperating connectors (not shown) to couple the housings 10, 12 together to provide the fully-assembled device 6. For example, the housings 10, 12 may include one or mating threads, detents, and the like, which may permanently couple the housings 10, 12 together. Alternatively, the connectors may allow the housings 10, 12 to be subsequently separated, e.g., after performing an injection, to remove the syringe 70, e.g., to allow the device 6 to be cleaned and reused with a new syringe.
[0048] In addition or alternatively, the housings 10, 12 may be permanently attached together by one or more of an interference fit between the ends 10a, 12b, bonding with adhesive, fusing, sonic welding, and the like. In another alternative, the outer housing 8 may be formed as a single, integral component into which the components of the device 6may be assembled. In these alternatives or even with a two-part housing, the device 6 may be a single use device, which may be disposed of after a single injection.
[0049] In the example shown in FIGS. 2A and 2B, the inner housing 20 includes a proximal cylinder 20a including the first chamber 22 and a distal cylinder 20b including the second chamber 24. Each of the proximal and distal cylinders 20a, 20b may have an elongate cylindrical wall or other cross-sectional shape along their lengths. The proximal and distal cylinders 20a, 20b may be permanently attached together to provide the inner housing 20, e.g., by one or more of cooperating threads, as shown, detents or other connectors, force fit, bonding with adhesive, sonic welding, fusing, and the like. Alternatively, the inner housing 20 may be formed as a single, unitary structure including the first and second chambers 22, 24. The proximal and distal cylinders 20a, 20b may be formed from materials similar to or different from the outer housing 8.
[0050] The inner housing 20 may be mounted within the outer housing 8 such the inner housing 20 remains substantially stationary within the outer housing 8. Similarly, the gas canister 40 may be mounted within the inner housing 20, e.g., within the first chamber 22, such that the gas canister 40 also remains substantially stationary relative to the outer housing 8. For example, one or more struts, supports, or other structures (not shown) may be provided on the inner and / or outer housings 20, 8 to secure the inner housing 20 and / or the gas canister 40 relative to the outer housing 8.
[0051] In the example shown, the proximal cylinder 20a may include an annular wall surrounding the first chamber 22 that includes a uniform diameter first region 22a within which the gas canister 40 is mounted, and second and third regions 22b, 22c within which the carriage 64 is slidably mounted, as described further elsewhere herein. The distal cylinder 20b may have a length such that a distal end 21b of the distal cylinder 20b may abut the syringe 70 when the device 6 is assembled.
[0052] Optionally, the distal end 21b may include one or more features that contact the proximal end 72b of the syringe 70, e.g., an O-ring 20d secured on or around the distal end 21b formed from resilient and / or relatively flexible material. The O-ring 20d may prevent the distal end 21b from damaging the syringe 70, e.g., if the barrel 72 is made from glass.
[0053] With continued reference to FIGS. 2A and 2B, the canister 40 includes a body 42 including a first closed end 42a, a second outlet end 42b, and a cap 44 welded or otherwise attached to the outlet end 42b to provide an enclosed cavity 48 filled with a fluidcontaining pressurized gas, such as carbon dioxide or fluorocarbon gases, compressed to sufficient pressure to least partially liquefy the gas within the cavity 48. Alternatively, fluids containing gases such as argon, nitrogen, helium argon, or other combinations thereof that remain in gaseous form may be stored within the cavity 48. As described elsewhere herein, the pressurized fluid contained within the cavity 48 may be used to generate the forces to operate the device 6, e.g., to inject one or more agents from the syringe 70 into a subject’s body.
[0054] In one example, the body 42 and cap 44 may be formed from stainless steel or other desired or suitable metal, plastic, or composite material, e.g., formed by one or more of drawing, stamping, machining, casting, molding, and the like. For example, the body 42 may be deep drawn from sheet metal, e.g., a round sheet metal blank of Type 305 stainless steel, using one or more dies and punches (not shown), to form a main barrel region, the enclosed end 42a, an optional tapered shoulder region, and the outlet end 42b defining an opening to which the cap 44 is attached.
[0055] As shown, the canister 40 may be oriented with the outlet end 42b proximal to the enclosed end 42a, and the carriage 64 may be provided proximal to the outlet end 44. In the example shown, the cap 44 may be an enclosed cap including a septum or other weakened region (not shown) that may be opened by the opener mechanism. In this example, the carriage 64 may include an opener pin 62 configured to puncture or preferentially tear the septum, as described elsewhere herein. Additional information regarding canisters that may be used and methods for making them may be found in U.S. Publication No. 2017 / 0258583, the entire disclosure of which is expressly incorporated by reference herein.
[0056] Alternatively, the cap 44 may include other closer mechanisms, such as a ball or other member (not shown) that may be biased or otherwise configured to close an outlet in the cap 44 yet may be directed away from the cap 44, e.g., into the canister 40, by the carriage 64 to open the outlet and release the pressurized gas within the cavity 48. In this alternative, the opener pin 62 may include a tapered tip (not shown) sized to enter the outlet and push the closure away from the outlet.
[0057] The plunger 50 may be an elongate rod or other member including a proximal end 52 that is slidably disposed within the second chamber 24, e.g., initially immediately adjacent the first chamber 22, and a distal end 54 coupled to the piston 74. The plunger 50 is movable from an initial or retracted position (e.g., shown in FIGS. 2A and 2B)to a final or extended position (e.g., shown in FIGS. 6A and 6B), e.g., wherein the distal end 54 extends from the second end 16 of the drive assembly 12 into the agent chamber 73 of the syringe 70.
[0058] A flange or other guide member 53 may be provided on the proximal end 52 of the plunger 50 that slidably engages a wall of the second chamber 24. Consequently, when pressurized gas enters the second chamber 24 (via the first chamber 22), the pressure generates a distal force to direct the plunger 50 distally from the initial position towards the extended position to advance the piston 74 and deliver the one or more agents from the agent chamber 73 through the needle 78 into the subject, as described further elsewhere herein.
[0059] Optionally, a wall, orifice, or intermediate passage (not shown) may be provided between the first and second chambers 22, 24. The intermediate passage may have a relatively small diameter to provide a restrictor to reduce pressure rise time within the second chamber 24. For example, the intermediate passage may i) slow down the transient flow of gas, slowing the rise of pressure imparted to the plunger 50, e.g., providing a soft-start to the injection, reducing / eliminating pressure shock waves in the fluid to be injected in the syringe and possibly reducing patient pain as the drug injection is gently initiated; and / or ii) slow down the steady state flow of gas, reducing the otherwise pressure imparted to the plunger 50, providing a limiting effect to the flow rate of the drug injected into the patient.
[0060] Optionally, as shown, the plunger 50 may also include a plunger chamber 56, e.g., extending from an open proximal end 52 of the plunger 50 to a closed distal end 54. The plunger chamber 56 may taper inwardly from the proximal end 52 to the distal end 54, as shown, or may have a uniform diameter or other cross-sectional shape along its length. Alternatively, the proximal end 52 of the plunger 50 may include a closed wall and / or the plunger 50 may be a solid rod between the proximal and distal ends 52, 54.
[0061] Optionally, the flange 53 on the proximal end 52 of the plunger 50 may include one or more passages (not shown) that extend between proximal and distal surfaces of the flange 53. For example, the flange 53 may include a plurality of circular or other enclosed passages spaced apart from one another around a circumference of the flange 53, each extending between the proximal and distal surfaces.
[0062] In this option, the flange 53 may be sized and / or shaped to slidably engage an inner wall of the second chamber 24, e.g., to allow the plunger 50 to move from theinitial to the extended position, but may not require O-rings or other seals. Instead, one or more O-rings or other seals may be provided within and / or adjacent the inner housing 20 to seal the first and second chambers 22, 24 and / or otherwise a flow path from the gas canister 40 to the plunger 50. For example, a first O-ring 58a may be provided between the inner housing 20 and the carriage 64, a second O-ring 58b may be provided between a distal end 21b of the inner housing 20 and the plunger 50, and / or a third O-ring 58c may be provided between the proximal and distal cylinders 10a, 10b, if provided as separate components secured together.
[0063] In one example, the plunger 50 includes a flange 53 formed as a cylindrical head having a larger outer diameter than the plunger 50, which may be integrally molded or otherwise formed with the plunger 50, or that is manufactured separately and permanently attached to the plunger 50, with one or more passages (not shown) extending between proximal and distal surfaces of the flange 53. When the canister 40 is opened to release the pressurized gas, the initial volume that the gas must fill the first chamber 22 around the canister 40, the second chamber 24 around the plunger 50 and, optionally, the plunger chamber 56, which may result in an initial pressure drop as the gas fills the available volume. However, as the plunger 50 advances, the change in volume that the gas must fill increases only minimally (e.g., the volume the plunger 50 occupies within the second chamber 24 that is displaced out of the distal end 16 of drive assembly 12). Consequently, because the volume change is minimized, the resulting force applied by the pressure on the plunger 50 may remain substantially constant or reduce only slightly. Thus, the resulting force drop applied to the plunger 50 may be minimized, which may provide a more uniform delivery rate of the agent from the syringe 70. Additional information regarding plungers that may provide reduced pressure drop can be found in co-pending U.S. application, Serial Nos. 17 / 965,707, the entire disclosure of which is expressly incorporated by reference herein.
[0064] Optionally, the proximal end 52 of the plunger 50 may have a larger diameter or other cross-section than the distal end 54 of the plunger 50. For example, the outer diameter or cross-section may taper between the proximal and distal ends 52, 54 of the plunger 50. Such a tapered shape may increase the cross-sectional area of the plunger 50 as it advances from the initial position towards the extended position, which may minimize the change in the distal force applied to the syringe stopper due to volume change, which may be particularly useful for applications where consistent rates of delivery are desired. It willbe appreciated that any of these optional features related to the plunger 50 may be combined together or omitted, as desired.
[0065] Returning to FIGS. 2A and 2B, the opener mechanism 60 includes a release cap 34 and a spring perch assembly or carriage 64 slidably coupled to the rear housing 12, e.g., within the second and third regions 22b, 22c of the first chamber 24. The carriage 64 carries the opener pin 62, e.g., mounted along the axis 18 and oriented distally towards the cap 44. The carriage 64 and release cap 34 include one or more features that disengage when the release cap 34 is directed proximally (by the activation cap 80 and spacer 30), and the carriage 64 may be biased to move distally, when released, to direct the opener pin distally to open the outlet in the cap 44 of the canister 40.
[0066] For example, the rear housing 12 and the carriage 64 may include cooperating features that prevent the carriage 64 from moving until the device 6 is activated. For example, as best seen in FIGS. 5A-5C, the carriage 64 includes locking tabs or other features 64a on its proximal end that engage the proximal end 13a of the rear housing 12, and a flange 64b on its distal end slidable within the second region 22b of the first chamber 24. A puncture spring 66 is also provided within the second region 22b around the carriage 64, e.g., a coil spring provided in an initially compressed state between the rear housing 12 and the flange 64b. Consequently, the spring 66 biases the carriage 64 to move distally, but for the locking features 64a engaging the proximal end 13a of the rear housing 12.
[0067] The release cap 34 and carriage 64 include cooperating features that release the locking features 64a from the rear housing 12 when the device 6 is activated. For example, as shown in FIGS. 5A-5C, the release cap 34 includes a cylindrical body surrounding a portion of the rear housing 12, e.g., around the second and third regions 22b, 22c of the first chamber 24. The release cap 34 may also include an enclosed proximal end 34a proximal to the proximal end 13a of the rear housing 12, and a distal end 34b that includes one or more features to limit axial movement of the release cap 34. For example, one or more flanges on the distal end 34b may slide proximally along the inner surface of the outer housing 8, e.g., until they abut a ridge on the outer housing 8 to prevent further proximal movement of the release cap 34, as described further elsewhere herein.
[0068] As shown, a central hub 36 is provided on the proximal end 34a of the release cap 34 aligned along the axis 18 distally towards the opener pin 62. The carriage 64 includes a plurality of tabs or release fingers 65, e.g., arranged concentrically around the axis 18 such that the tabs 65 may slide along the hub 36 as the release cap 34 is directedproximally. Once the hub 36 moves proximally beyond the tabs 65, the tabs 65 are biased to move radially inwardly (towards the central axis 18), thereby directing the locking features 64a inwardly. Once the locking features 64a clear the proximal end 13a of the rear housing 12, e.g., as shown in FIG. 5C, the spring 66 may automatically direct the carriage 64 distally, thereby directing the opener pin 62 distally to penetrate the septum in the cap 44 of the canister 40 (or otherwise opening the outlet).
[0069] During use, the device 6 may be provided initially with the safety cap 86 attached to the distal end 8b of the housing 8, e.g., as shown in FIGS. 1-2B. Immediately before performing an injection, the safety cap 86 may be removed, e.g., by simply pulling the safety cap 86 distally away from the outer housing 8, to expose the contact surface 84 of activation cap 80, e.g., as shown in FIG. 4A. For example, as best seen in FIGS. 3A and 3B, the safety cap 86 may include inner and outer cylindrical members with the proximal end 86a of the inner member coupled to the needle shield 79 and a proximal end 86b of the outer member slidably received over the distal end 8b of the outer housing 8. Alternatively, the safety cap 86 and / or outer housing 8 may include one or more connectors, locks, and the like (not shown) that may be disengaged before removing the safety cap 86.
[0070] As described elsewhere herein, the safety cap 86 may prevent the activation cap 80 from being directed proximally, e.g., by preventing the activation cap 80 from being contacted. In addition or alternatively, the safety cap 86 may include features that engage the needle shield 79 such that, when the safety cap 86 is removed, the needle shield 79 is also removed. The safety cap 86 and needle shield 79 may prevent the needle 78 from being exposed from the housing 8 prior to use. Once the safety cap 86 and needle shield 79 are removed, the device 6 is ready to be used to perform an injection.
[0071] Turning to FIGS. 4A-4C, the contact surface 84 may be placed against a subject’s skin (not shown) and then the device 6 may be pressed against the skin to insert the needle 78, thereby causing the activation cap 80 to slide proximally from the initial position shown in FIG. 4A to the retracted position shown in FIG. 4B as the needle 78 enters the subject’s skin. As described further below, this action may activate the opener mechanism 60 to cause the opener pin 62 to open the outlet of the gas canister 40 to release pressurized gas into the first chamber 22, whereupon the pressurized has may advance the plunger 50 and, consequently, the piston 74 to deliver the agent(s) through the needle 78 into the subject.
[0072] For example, as shown in FIG. 4A, initially, the proximal end 82 of the activation cap 80 may abut or otherwise engage a distal end 30a of the spacer 30, and a proximal end 30b of the spacer 30 may abut or otherwise engage the distal end 34b of the release cap 34. Consequently, when the activation cap 80 is retracted proximally within the outer housing 8, its proximal end 82 pushes the distal end 30a of the spacer 30, thereby directing the spacer 30 proximally, and, in turn, the proximal end 30b of the spacer 30 pushes the distal end 34b of the release cap 34, thereby directing the release cap 34 proximally, e.g., until the proximal end 34a of the release cap 34 contacts the proximal end 8c of the outer housing 8.
[0073] As the activation cap 80, spacer 30, and release cap 34 move proximally, the inner housing 20 (and canister 40 within the first chamber 22) may remain substantially stationary. As can be seen in FIGS.4A and 4B, as the spacer 30 is directed proximally, the spring 32 may be compressed, e.g., between features on the distal end 30a of the spacer 30 and the inner housing 20, thereby biasing the spacer 30 subsequently to move distally. However, with the operator pressing the contact surface 84 of the activation cap 80 against the subject’s skin, the spacer 30 is unable to move distally.
[0074] Since the carriage 64 is secured relative to the inner housing 20 by the locking features 64a, the carriage 64 also remains substantially stationary, such that the release cap 34 moves proximally relative to the carriage 64 and the tabs 65 on the carriage 64 slide along the hub 36 on the release cap 34, as best seen in FIGS. 5A-5C. When the release cap 34 reaches its proximal-most position, e.g., shown in FIGS. 4C and 5C, the hub 36 has moved proximally beyond the ends of the tabs 65 and, given the inward bias of the tabs 65, the tabs 65 are released and automatically move inwardly. Given that the tabs 65 are coupled to the locking features 64a on the carriage 64, the inward movement of the tabs 65 causes the locking features 64a to move inwardly, thereby disengaging the locking features 64a from the proximal end 21a of the inner housing 20.
[0075] Due to the spring 66, the carriage 64 is then released and biased to move distally, thereby advancing the opener pin 62 distally to open the outlet of the canister 40, as shown in FIGS. 4C and 5C. The release cap 34 may include one or more tabs or other features 34c, e.g., corresponding to the pockets 8d in the outer housing 8, such that, when the release cap 34 reaches its distal-most position, the tabs 34c are received in respective pockets 8d, as shown. Thus, the tabs 34c may prevent the release cap 34 from moving distally as the carriage 64 advances distally due to the spring 66.
[0076] When the carriage 64 moves distally, it causes the opener pin 62 to advance and penetrate the septum in the cap 44 (or otherwise open the outlet), thereby releasing the pressurized gas within the canister 40. The released pressurized gas then enters the first chamber 22, e.g., around the canister 40, and passes to the second chamber 24, thereby pressurizing the second chamber 24 to generate a distal force to direct the plunger 50 distally from the initial position towards its extended position to deliver the one or more agents from the syringe 70 through the needle 78 into the subject, e.g., as shown in FIG. 6A.
[0077] The operator may monitor the syringe 70 during the injection, e.g., via the window(s) 8c to confirm that the piston 74 has fully advanced distally within the barrel 72 to deliver the entire dose into the subject. Once the injection is completed, the device 6 may be directed away from the subject, thereby withdrawing the needle 78 from the subject’s skin. As the device 6 is directed away from the subject’s skin, the activation cap 80 is free to move distally and, due to the distal bias of the spring 32, the spacer 30 automatically advances distally, thereby directing the activation cap 80 distally to cover the needle 78 as it is withdrawn.
[0078] As best seen in FIG. 6C, as the spacer 30 advances distally, the proximal end 30b of the spacer may pass distally beyond features 34d on the distal end 34b of the release cap 34. For example, the features 34b may include one or more fingers or tabs that slide along the interior of the spacer 30 until the proximal end 30b passes distally, whereupon the tabs may resiliently move radially outwardly, e.g., such that the tabs 34d are located proximal to the proximal end 30b of the spacer 30, thereby preventing the spacer 30 from subsequently moving proximally. With the spacer 30 prevented from moving proximally, the activation cap 80 is unable to retract again, thereby locking the activation cap 80 extended over the needle 78 and preventing accidental exposure of the needle 78.
[0079] If the device 6 is a single-use device, the device 6 may then be disposed of. If the device is reusable, e.g., if the forward and rear housings 10, 12 are separable, the rear housing 12 may subsequently be separated from the forward housing 10, and the syringe 70 may be removed. For a reusable device, one or more features may be provided within the device to release any residual pressure within the first and second chambers 22, 24. For example, as shown in FIGS. 6A and 6B, a gas valve and / or shaft member may be provided within the plunger 50, which may be manipulated to release the pressurized gas before removing decoupling the plunger 50 from the piston 74. The separate housings 10, 12 maythen be cleaned and / or sterilized and a new gas canister 40 may be loaded into the inner housing 20 before reassembling the device.
[0080] Turning to FIG. 7A, a cross-sectional detail of an exemplary injector device 6 is shown, e.g., similar to the device 6 shown in FIGS. 1-6, with some components omitted for clarity. As described previously, the gas canister 40 and opener mechanism 60 occupy substantial space within a drive module 12 of the injector device 6. In particular, as shown, the canister 40 and opener mechanism 60 are mounted axially within the inner housing 20 proximal to the plunger 50, thereby dictating a minimum axial length for the drive module 12, i.e., a sum of the lengths of the plunger 50, the canister 40, and the opener mechanism 60 along the axis 18.
[0081] Similarly, FIG. 7B shows an alternative example of an injector device 6’ in which the gas canister 40 is oriented distally rather than proximally as shown in FIG. 7A. In this alternative, the opener mechanism is omitted but necessarily occupies some space between the canister 40 and the plunger 50.” Thus, the device 6’ has a minimum axial length based on the lengths of the plunger 50,’ the opener mechanism, and the canister 40.
[0082] Generally, the plunger 50, 50’ (also referred to herein as a “force providing component” since it applies the distal force to the piston 74 of the syringe 70) is the longest component of the drive module 12, having a length corresponding to the length of the syringe 70 to ensure delivery of the entire dose of agent(s) contained within the agent chamber 73 of the syringe 70. Given this length, a second chamber 24 within the inner housing 20, which initially contains the plunger 50, will have a corresponding length and volume. Thus, the canister 40 must have sufficient volume and pressure of the pressurized gas to fill the first chamber 22 around the canister 40 as well as the second chamber 24 and any interior plunger chamber 56, while providing the desired distal force on the plunger 50 to advance the piston 74.
[0083] Thus, it would be useful to provide an injector device that reduces this overall length, thereby providing a more compact injector device, which may easy handling and use, and / or which may reduce the overall volume that must be filled by the pressurized gas from the gas canister.
[0084] For example, turning to FIGS. 8A and 8B, an example of an injector device 106 is shown, which includes a drive module 112 including an inner housing 120 and a plunger 150 slidably disposed within a housing chamber 124. The device 106 may include other components, e.g., an outer housing, actuator, and the like, e.g., similar to the device 6,which are omitted for clarity. Unlike the device 6, a canister 40 and opener mechanism 160 are provided that are nested within an interior plunger chamber 156 within the plunger 150. Consequently, when the plunger 150 is advanced from its proximal or initial position (FIG. 8A) towards its distal or extended position (FIG. 8B), the canister 40 and opener mechanism 160 may remain substantially stationary relative to the plunger 150, i.e., moving axially relative to the inner housing 120 along with the plunger 150.
[0085] Although the inner housing 120 is shown as being comparable to the inner housing 12 shown in FIG. 7A, it will be appreciated that the proximal region 122 within the inner housing 120 (similar to the first chamber 22 in the device 6) may be omitted in the device 106, which may substantially reduce the axial length of the drive module 112, e.g., by the length reduction L shown in FIG. 8A. If the proximal region 122 is omitted, the overall volume within the drive module 112 that is exposed to pressurized gas may also be substantially reduced.
[0086] For example, as shown, the canister 40 may be mounted within the plunger chamber 156 with its cap 44 and outlet oriented proximally away from the plunger 150. The canister 40 may be secured within a seat within the plunger chamber 156 such that the canister 40 is stationary relative to the plunger 150. The opener mechanism 160 may be provided within the plunger chamber 156 proximal to the canister cap 44 and may include a spring perch assembly or carriage 164 carrying an opener pin 162, which is initially spaced apart from the outlet of the cap 44, e.g., similar to the devices described previously.
[0087] For example, the carriage 164 may be biased to move distally, e.g., by spring 166 or other biasing mechanism, but may be initially locked relative to the plunger 150, e.g., using similar features to the device 6 described previously. The device 160 may also include an actuator (not shown), e.g., including an activation cap and / or spacer (not shown) around the syringe 70 and / or inner housing 120, which may be activated when the device 160 is pressed against a patient’s skin to insert the needle 78 to perform an injection. The actuator may release the carriage 164, whereupon the spring 166 may displace the carriage 164 and, consequently the opener pin 162, to open a septum or other outlet in the cap 44 of the canister 40. Alternatively, a manual actuator, such as a button or dial (not shown), may be provided on the drive module 120 that may be operatively coupled to the carriage 164 to release the carriage 164 and direct the opener pin 162 to open the outlet when activated by a user.
[0088] Once the outlet of the canister 40 is opened, pressurized gas within the canister 40 may then be released and pass into the plunger chamber 156 and the chamber 124 within the inner housing 120, thereby applying a distal force to the plunger 150 to direct the plunger 150, and consequently, the piston 74, distally to deliver the agent(s) within the syringe chamber 73, similar to the other devices herein. With the canister 40 and opener mechanism 160 nested within the plunger 150, the canister and opener mechanism 160 travel distally with the plunger 150, as shown in FIG. 8B. Thus, although the carriage 164 of the opener mechanism 160 may displace initially within the plunger 150 to direct the opener pin 162 to open the canister outlet, the carriage 164 may subsequently remain substantially stationary relative to the plunger 150.
[0089] Alternatively, if desired, the operation of the canister 40 and carriage 164 may be reversed, i.e., the canister 40 may be mounted within the plunger chamber 156 such that the canister 40 may move axially when the device is activated, to cause the opener pin on a stationary opened mechanism to open the outlet. Thereafter, in this alternative, the canister may subsequently remain stationary and move distally with the plunger 150.
[0090] It will be appreciated that the volume that must be filled by the pressurized gas from the canister 40 may only need fill the remaining volume of the plunger chamber 156 around and / or distal to the canister 40 and the chamber 124 within the inner housing 120 proximal to the plunger 150 as it moves distally. Thus, the volume and / or pressure of the gas within the canister 40 may be reduced compared to the device 6 shown in FIG. 7A (while providing the same desired distal force), since the region 122 corresponding to the length reduction L may be omitted from the device 106.
[0091] Turning to FIGS. 9A and 9B, another example of an injector device 206 is shown that includes a syringe 70 and a drive module 212 including an inner housing 220 (and may include other components, e.g., an outer housing, actuator, and the like, similar to the previous devices, which are omitted for clarity). Unlike the previous devices, the device 206 includes a combination plunger / gas canister 250 that includes a proximal end 252, a distal end 254, which may be operatively coupled to the piston 74 of the syringe 70, and an interior plunger chamber 256. An outlet 258 may be provided on the proximal end 252, e.g., including a septum or other closure (not shown), which is initially closed but may be opened by an opener mechanism 266 (not shown). For example, the opener mechanism may include a carriage carrying an opener pin (not shown), which may be initially spaced apart from the outlet 258 and, when the device 206 is activated, the opener pin may bedisplaced axially to open the outlet 258 and release the pressurized gas within the plunger chamber 256, similar to the previous devices.
[0092] Once the outlet 258 is opened, the pressurized gas may fill the chamber 224 within the inner housing 220, thereby applying a distal force to direct the plunger 250 distally, and consequently direct the piston 74 distally to deliver the agent(s) within the syringe chamber 73 through the needle 78 into the patient’s body.
[0093] Again, it will be appreciated that a proximal region of the inner housing 220 may be reduced by the length reduction L, which may reduce the overall length of the device 206 and / or reduce the volume of pressurized gas needed to fully advance the plunger 250.
[0094] While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the scope of the appended claims.
Claims
WE CLAIM:
1. A drive module for delivering one or more agents into a patient’s body from an injector module comprising an agent chamber containing one or more agents, an outlet, and a piston, the drive module comprising: a drive housing including a first end and a second end and a first chamber therein; a plunger comprising a proximal end disposed within the first chamber and slidable from an initial position to an extended position wherein a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger configured to be coupled to the piston of the injector module; a canister at least partially received in the plunger such that the canister follows movement of the plunger, the canister containing pressurized gas and including an outlet; an opener mechanism within the drive housing including an actuator pin disposed adjacent the outlet; and an actuator configured to move one of the opener mechanism and the canister to cause the actuator pin to open the outlet and cause the gas within the canister to flow into the first chamber to advance the plunger and canister, the plunger configured to advance the piston of the injector module to deliver the one or more agents from the agent chamber.
2. The drive module of claim 1, wherein the plunger comprises a plunger chamber extending between the proximal and distal ends and wherein the canister is mounted within the plunger chamber.
3. The drive module of claim 2, wherein the plunger chamber is open at the proximal end such that pressurized gas released from the canister passes from the plunger chamber into the first chamber, and wherein the plunger chamber is closed at the distal end such that the released pressurized gas applies a distal force on the plunger to direct the plunger from the initial position to the extended position.
4. The drive module of claim 2, wherein the opener mechanism is mounted within the plunger chamber adjacent the outlet.
5. The drive module of claim 4, wherein the opener mechanism comprises a carriage carrying the opener pin spaced apart from the outlet, the actuator configured torelease the carriage when activated whereupon the carriage displaces within the plunger chamber to open the outlet.
6. The drive module of claim 5, wherein the opener mechanism further comprises a release cap operatively coupled to the actuator such that, when the actuator is activated, the release cap displaces relative to the plunger to release the carriage, whereupon the carriage displaces within the plunger chamber to open the outlet.
7. The drive module of claim 6, further comprising locking elements securing the carriage within the plunger chamber and wherein, when the release cap displaces, the locking elements release the carriage, the carriage biased to move towards the canister to cause the opener pin to open the outlet.
8. The drive module of claim 4, wherein the canister comprises a septum closing the outlet, and wherein the opener pin is configured to tear or puncture the septum to open the outlet when the carriage displaces within the plunger chamber.
9. The drive module of any one of claims 2-8, wherein the canister is axially fixed relative to the plunger such that the canister moves distally with the plunger.
10. The drive module of claim 9, wherein the carriage is mounted within the plunger chamber such that, after initially being displaced to open the outlet, the carriage moves distally with the plunger.
11. The drive module of any one of claims 1-8, wherein the actuator comprises an actuator sleeve that is configured to retract when the injector module is pressed against a patient’s skin, the actuator sleeve operatively coupled to the opener mechanism to release the opener mechanism to cause the actuator pin to open the outlet.
12. The drive module of any one of claims 1-8, wherein the actuator comprises a manual actuator configured to be manually activated by a user to actuate the opener mechanism to open the outlet.
13. The device of claim 12, wherein the manual actuator comprises one of a screw, a button, and a lever.
14. A drive module for delivering one or more agents into a patient’s body from an injector module comprising an agent chamber containing one or more agents, an outlet, and a piston, the drive module comprising: a drive housing including a first end and a second end and a first chamber therein; a plunger comprising a proximal end disposed within the first chamber and slidable from an initial position to an extended position wherein a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger configured to be coupled to the piston of the injector module; a plunger chamber within the plunger containing pressurized gas and including an outlet adjacent the proximal end; an opener mechanism within the drive housing including an actuator pin disposed adjacent the outlet; and an actuator configured to move one of the opener mechanism and the canister to cause the actuator pin to open the outlet and cause the gas within the canister to flow into the first chamber to advance the plunger, the plunger configured to advance the piston of the injector module to deliver the one or more agents from the agent chamber.
15. The drive module of claim 14, wherein the opener mechanism is mounted within the first chamber adjacent the proximal end of the plunger.
16. The drive module of claim 15, wherein the opener mechanism comprises a carriage carrying the opener pin spaced apart from the outlet, the actuator configured to release the carriage when activated whereupon the carriage displaces within the plunger chamber to open the outlet.
17. The drive module of claim 16, wherein the opener mechanism further comprises a release cap operatively coupled to the actuator such that, when the actuator is activated, the release cap displaces relative to the plunger to release the carriage, whereupon the carriage displaces within the plunger chamber to open the outlet.
18. The drive module of claim 16, further comprising locking elements securing the carriage within the plunger chamber and wherein, when the release cap displaces, the locking elements release the carriage, the carriage biased to move towards the canister to cause the opener pin to open the outlet.
19. The drive module of any one of claims 14-18, wherein the plunger comprises a septum closing the outlet, and wherein the opener pin is configured to tear or puncture the septum to open the outlet.
20. The drive module of any one of claims 14-18, wherein the actuator comprises an actuator sleeve that is configured to retract when the injector module is pressed against a patient’s skin, the actuator sleeve operatively coupled to the opener mechanism to release the opener mechanism to cause the actuator pin to open the outlet.
21. The drive module of any one of claims 14-18, wherein the actuator comprises a manual actuator configured to be manually activated by a user to actuate the opener mechanism to open the outlet.
22. A device for delivering one or more agents into a patient’s body, comprising: a) an injector module comprising an injector housing carrying an agent chamber containing one or more agents, and a piston slidably disposed within the agent chamber; and b) a drive module comprising: a drive housing including a first end and a second end and a first chamber therein; a plunger comprising a proximal end disposed within the first chamber and slidable from an initial position to an extended position wherein a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger coupled to the piston of the injector module; a canister at least partially received in the plunger such that the canister follows movement of the plunger, the canister containing pressurized gas and including an outlet; an opener mechanism within the drive housing including an actuator pin disposed adjacent the septum; and an actuator configured to move one of the opener mechanism and the canister to cause the actuator pin to open the outlet and cause the gas within the canister to flow intothe first chamber to advance the plunger and canister, wherein the plunger advances the piston of the injector module to deliver the one or more agents from the agent chamber from the agent chamber.
23. The device of claim 22, wherein the injector module is connectable to the second end of the drive housing.
24. The device of claim 22, wherein the injector module comprises a syringe.
25. The device of claim 22, wherein the injector module and the drive module are integrally contained within an outer housing.
26. The device of claim 22, wherein the plunger comprises a plunger chamber extending between the proximal and distal ends and wherein the canister is mounted within the plunger chamber.
27. The device of claim 22, wherein the plunger chamber is open at the proximal end such that pressurized gas released from the canister passes from the plunger chamber into the first chamber, and wherein the plunger chamber is closed at the distal end such that the released pressurized gas applies a distal force on the plunger to direct the plunger from the initial position to the extended position.
28. The device of claim 22, wherein the opener mechanism is mounted within the plunger chamber adjacent the outlet.
29. The device of claim 28, wherein the opener mechanism comprises a carriage carrying the opener pin spaced apart from the outlet, the actuator configured to release the carriage when activated whereupon the carriage displaces within the plunger chamber to open the outlet.
30. The device of claim 29, wherein the opener mechanism further comprises a release cap operatively coupled to the actuator such that, when the actuator is activated, therelease cap displaces relative to the plunger to release the carriage, whereupon the carriage displaces within the plunger chamber to open the outlet.
31. The device of claim 30, further comprising locking elements securing the carriage within the plunger chamber and wherein, when the release cap displaces, the locking elements release the carriage, the carriage biased to move towards the canister to cause the opener pin to open the outlet.
32. The device of claim 29, wherein the canister comprises a septum closing the outlet, and wherein the opener pin is configured to tear or puncture the septum to open the outlet when the carriage displaces within the plunger chamber.
33. The device of any one of claims 22-32, wherein the canister is axially fixed relative to the plunger such that the canister moves distally with the plunger.
34. The device of claim 33, wherein the carriage is mounted within the plunger chamber such that, after initially being displaced to open the outlet, the carriage moves distally with the plunger.
35. The device of any one of claims 22-32, wherein the actuator comprises an actuator sleeve that is configured to retract when the injector housing is pressed against a patient’s skin to insert a needle of the injector module, the actuator sleeve configured to release the opener mechanism to cause the actuator pin to open the outlet and release the pressurized gas.
36. The device of any one of claims 22-32, wherein the actuator comprises a manual actuator on the drive module that may be manually activated by a user to actuate the opener mechanism to open the septum and release the pressurized gas.
37. The device of claim 36, wherein the manual actuator comprises one of a screw, a button, and a lever.
38. A device for delivering one or more agents into a patient’s body, comprising:a) an injector module comprising an injector housing carrying an agent chamber containing one or more agents, and a piston slidably disposed within the agent chamber; and b) a drive module comprising: a drive housing including a first end and a second end and a first chamber therein; a plunger comprising a proximal end disposed within the first chamber and slidable from an initial position to an extended position wherein a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger coupled to the piston of the injector module; a plunger chamber within the plunger containing pressurized gas and including an outlet adjacent the proximal end; an opener mechanism within the drive housing including an actuator pin disposed adjacent the outlet; and an actuator configured to move one of the opener mechanism and the canister to cause the actuator pin to open the outlet and cause the gas within the canister to flow into the first chamber to advance the plunger, the plunger configured to advance the piston of the injector module to deliver the one or more agents from the agent chamber.
39. The device of claim 38, wherein the opener mechanism is mounted within the first chamber adjacent the proximal end of the plunger.
40. The device of claim 39, wherein the opener mechanism comprises a carriage carrying the opener pin spaced apart from the outlet, the actuator configured to release the carriage when activated whereupon the carriage displaces within the plunger chamber to open the outlet.
41. The device of claim 40, wherein the opener mechanism further comprises a release cap operatively coupled to the actuator such that, when the actuator is activated, the release cap displaces relative to the plunger to release the carriage, whereupon the carriage displaces within the plunger chamber to open the outlet.
42. The device of claim 40, further comprising locking elements securing the carriage within the plunger chamber and wherein, when the release cap displaces, thelocking elements release the carriage, the carriage biased to move towards the canister to cause the opener pin to open the outlet.
43. The device of any one of claims 38-42, wherein the plunger comprises a septum closing the outlet, and wherein the opener pin is configured to tear or puncture the septum to open the outlet.
44. The device of any one of claims 38-42, wherein the actuator comprises an actuator sleeve that is configured to retract when the injector module is pressed against a patient’s skin, the actuator sleeve operatively coupled to the opener mechanism to release the opener mechanism to cause the actuator pin to open the outlet.
45. The device of any one of claims 38-42, wherein the actuator comprises a manual actuator configured to be manually activated by a user to actuate the opener mechanism to open the outlet.
46. The device of claim 45, wherein the manual actuator comprises one of a screw, a button, and a lever.
Citation Information
Patent Citations
Multiple chamber syringe piston and mixing devices
US20180093040A1
injector
US20190117894A1
Injection devices and methods for making and using them
US20190167906A1
Chemically driven auto-injector with retraction
US20200197611A1
Manual insertion auto-injectors and methods for use
US20240033434A1